Diabetes prescriptions top 40 million in England after 50 per cent rise in six years
Diabetes prescriptions have for the first time topped 40m in year, a rise of nearly 50% in six years.
The net cost of diabetes drugs also rose by just under 50% in the same period, according to Prescribing for Diabetes in England: 2005/06 to 2011/12.
This growth is a faster and greater than for prescriptions overall, where items increased by 33% and net ingredient cost rose by just under 11% in the same period.
The report from the Health and Social Care Information Centre focuses on primary care, shows diabetes drugs are taking up a bigger share of both total drugs dispensed and the total net cost to the NHS each year.